{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:24:21Z","timestamp":1773152661338,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1067\/mai.2002.126676","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T21:24:11Z","timestamp":1034198651000},"page":"484-488","source":"Crossref","is-referenced-by-count":118,"title":["The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: A single-blind, placebo-controlled, crossover clinical study"],"prefix":"10.1067","volume":"110","author":[{"given":"Z\u00fclal","family":"Erbagci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1067\/mai.2002.126676_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0091-6749(96)70060-X","article-title":"Chronic urticaria: pathophysiology and treatment approaches","volume":"98","author":"Tharp","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126676_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1997.03890440085013","article-title":"The pathogenesis of chronic idiopathic urticaria","volume":"133","author":"Sabroe","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1067\/mai.2002.126676_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-199856020-00010","article-title":"Montelukast","volume":"56","author":"Markham","year":"1998","journal-title":"Drugs"},{"key":"10.1067\/mai.2002.126676_bib4","first-page":"209","article-title":"A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults","volume":"11","author":"Capella","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1067\/mai.2002.126676_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archderm.134.7.785","article-title":"The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis","volume":"134","author":"Carucci","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mai.2002.126676_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mjd.2001.111352","article-title":"The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis","volume":"44","author":"Yanase","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mai.2002.126676_bib7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0091-6749(98)70032-6","article-title":"Successful treatment of chronic urticaria with leukotriene antagonists","volume":"102","author":"Ellis","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126676_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0091-6749(98)70374-4","article-title":"Antileukotrienes in chronic urticaria [letter]","volume":"101","author":"Spector","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1067\/mai.2002.126676_bib9","first-page":"S155","article-title":"Zafirlukast (Accolate) in the treatment of chronic idiopathic urticaria\u2014a case series [abstract]","volume":"101","author":"Chiu","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1067\/mai.2002.126676_bib10","first-page":"S128","article-title":"Leukotrienes and cytokines in steroid dependent chronic urticaria [abstract]","volume":"101","author":"Norris","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126676_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1081-1206(10)62677-4","article-title":"Leukotriene modifiers in chronic urticaria [letter]","volume":"83","author":"Bensch","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2002.126676_bib12","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1365-2222.2001.01189.x","article-title":"Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and\/or acetylsalicylic acid","volume":"31","author":"Pacor","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2002.126676_bib13","first-page":"99","article-title":"Comparison of montelukast and fexofenadine for chronic idiopathic urticaria [letter]","volume":"137","author":"Nettis","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1067\/mai.2002.126676_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1034\/j.1398-9995.2001.056005456.x","article-title":"Leukotriene receptor antagonists in chronic urticaria","volume":"56","author":"Asero","year":"2001","journal-title":"Allergy"},{"key":"10.1067\/mai.2002.126676_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/000155500750043168","article-title":"Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast [letter]","volume":"80","author":"Hani","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1067\/mai.2002.126676_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1398-9995.2000.00538.x","article-title":"Successful treatment of delayed pressure urticaria with montelukast","volume":"55","author":"Berkun","year":"2000","journal-title":"Allergy"},{"key":"10.1067\/mai.2002.126676_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1081-1206(10)62457-X","article-title":"Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria","volume":"85","author":"Asero","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2002.126676_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1081-1206(10)62354-X","article-title":"Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast","volume":"86","author":"Simons","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2002.126676_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2133.1998.02129.x","article-title":"Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist","volume":"138","author":"Ohnishi-Inoue","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mai.2002.126676_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0091-6749(99)70008-4","article-title":"Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma","volume":"104","author":"Volovitz","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126676_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.1999.02707.x","article-title":"The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria","volume":"140","author":"Sabroe","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1067\/mai.2002.126676_bib22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1986.tb04065.x","article-title":"A serological mediator in chronic idiopathic urticaria\u2014a clinical, immunological and histological evaluation","volume":"114","author":"Grattan","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1067\/mai.2002.126676_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2133.1998.02033.x","article-title":"Intravenous immunoglobulin in autoimmune chronic urticaria","volume":"138","author":"O'Donnell","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mai.2002.126676_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"key":"10.1067\/mai.2002.126676_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(84)90686-X","article-title":"H1-receptor-active histamine not sole cause of chronic idiopathic urticaria","volume":"2","author":"Krause","year":"1984","journal-title":"Lancet"},{"key":"10.1067\/mai.2002.126676_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186.000441","article-title":"Arachidonic acid metabolism","volume":"55","author":"Needleman","year":"1986","journal-title":"Annu Rev Biochem"},{"key":"10.1067\/mai.2002.126676_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(98)00440-3","article-title":"Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice","volume":"353","author":"Andoh","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1067\/mai.2002.126676_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/1523-1747.ep12531738","article-title":"Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4) in human skin","volume":"80","author":"Soter","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mai.2002.126676_bib29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0091-6749(05)80180-0","article-title":"Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic urticaria and in normal subjects","volume":"86","author":"Maxwell","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126676_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0091-6749(91)90217-C","article-title":"The effect of the oral leukotriene antagonist, ICI 204, 219, on leukotriene D4 and histamine-induced cutaneous vascular reactions in man","volume":"87","author":"Bernstein","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2002.126676_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/mai.2000.104939","article-title":"Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression. Inhibitory effects of anti-inflammatory drugs","volume":"105","author":"Wedi","year":"2000","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T07:21:35Z","timestamp":1554794495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674902001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0091674902001409"],"URL":"https:\/\/doi.org\/10.1067\/mai.2002.126676","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}